TGFB1 and neoplasm: In normal tissue and early tumours, it acts as a potent tumour suppressor, but with loss or inactivation of TGFβ downstream signalling it becomes a tumour promotor, inducing EMT, metastasis, angiogenesis, stromal changes and an immunosuppressive TME.